Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000914208-25-000277
Filing Date
2025-08-07
Accepted
2025-08-07 15:19:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5584
  Complete submission text file 0000914208-25-000277.txt   7649
Mailing Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309
Business Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Subject) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90866 | Film No.: 251193494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)